Search results for "subjects"

showing 10 items of 1268 documents

Profesors Alberts Varslavāns: biobibliogrāfiskais rādītājs

1990

Saturs: Priekšvārds. Vēstures zinātņu doktors profesors Alberts Varslavāns. Profesora vēstures zinātņu doktora A. Varslavāna publicētie darbi (1962.-1989.) Profesora A. Varslavāna rediģētie darbi. Profesora A. Varslavāna vadītās disertācijas. Raksti par profesoru A. Varslavānu. A. Varslavāna darbu alfabētiskais radītājs. Personu rādītājs.

Biobibliogrāfiskie rādītājiJauno laiku vēsture - bibliogrāfijaProfessors of the Latvian UniversityHistory of the University of Latvia:HUMANITIES and RELIGION::History and philosophy subjects::History subjects::History [Research Subject Categories]Vēstures zinātne - bibliogrāfijaJaunāko laiku vēsture - bibliogrāfijaLatvijas Universitātes vēstureLatvijas Universitātes profesoriVēstures zinātņu profesori Latvijas UniversitātēP. Stučkas Latvijas Valsts universitātes profesori
researchProduct

Profesors Rihards Treijs: biobibliogrāfiskais rādītājs

1991

Saturs: Priekšvārds. Vēstures zinātņu doktors profesors Rihards Treijs. / A. Kleckins / Profesora R. Treija publicētie darbi (1958. - 1990.) Profesora R. Treija darbu alfabētiskais rādītājs. Personu rādītājs.

Biobibliogrāfiskie rādītājiProfessors of the Latvian UniversityHistory of the University of Latvia:HUMANITIES and RELIGION::History and philosophy subjects::History subjects::History [Research Subject Categories]Latvijas Universitātes vēstureLatvijas Universitātes profesoriLatvijas vēsture - bibliogrāfijaVēstures zinātņu profesori Latvijas UniversitātēP. Stučkas Latvijas Valsts universitātes profesoriŽurnālistikas vēsture - bibliogrāfija
researchProduct

Profesors Vitolds Rajevskis: biobibliogrāfiskais rādītājs

1990

Saturs: Priekšvārds. Vēstures zinātņu doktors profesors Vitolds Rajevskis. / A. Favorskis / Profesora V. Rajevska publicētie darbi (1955.-1988.). Raksti par profesoru V. Rajevski. Profesora V. Rajevska publicēto darbu alfabētiskais rādītājs. Personu rādītājs.

Biobibliogrāfiskie rādītājiProfessors of the Latvian UniversityHistory of the University of Latvia:HUMANITIES and RELIGION::History and philosophy subjects::History subjects::History [Research Subject Categories]Latvijas Universitātes vēstureLatvijas Universitātes profesoriVēstures zinātņu profesori Latvijas UniversitātēP. Stučkas Latvijas Valsts universitātes profesoriPSKP vēsture - bibliogrāfiskais rādītājsKomunistiskā partija Latvijā - bibliogrāfiskais rādītājsКоммунистическая партия - библиографический указатель
researchProduct

Montas Kromas bibliogrāfija

2022

BiogrāfijasLatviešu dzeja:HUMANITIES and RELIGION::Aesthetic subjects::Literature [Research Subject Categories]Latviešu autoriKroma Monta (1919-1994)
researchProduct

Duration of untreated psychosis in first-episode psychosis is not associated with common genetic variants for major psychiatric conditions: results f…

2021

The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010–241909 (Project EU-GEI).

Bipolar DisorderTime FactorsIntelligenceGenome-wide association studyDETERMINANTSpsychosi0302 clinical medicineInterquartile rangeSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.IMPUTATIONpolygenic scorepsychosis0303 health sciencesConfoundingEuropePsychiatry and Mental healthgenome-wide association studieSchizophreniaMajor depressive disorderlipids (amino acids peptides and proteins)Case-Control Studieduration of untreated psychosisBrazilHumanAdultPsychosismedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesTime FactorAcademicSubjects/MED00810DISORDERS1ST EPISODEILLNESSPsychotic Disorderduration of untreated psychosi03 medical and health sciencesInternal medicinemedicineHumansBipolar disorderGENOME-WIDE ASSOCIATIONSettore MED/25 - PsichiatriaMETAANALYSIS030304 developmental biologyDepressive Disorder Majorbusiness.industryCOMPONENTSTREATMENT DELAYmedicine.diseaseTRANSTORNO BIPOLARschizophreniapolygenic scoresPsychotic DisordersCase-Control Studiesdupgenome-wide association studiesbusiness030217 neurology & neurosurgeryRegular ArticlesGenome-Wide Association Study
researchProduct

Effect of Fibre-Enriched Orange Juice on Postprandial Glycaemic Response and Satiety in Healthy Individuals: An Acute, Randomised, Placebo-Controlled…

2019

Background: Consumption of fibre-enriched orange juice may be an appropriate way to supplement daily fibre intake and achieve beneficial effects on metabolic health. The present study aimed to assess the short-term effects of fibre-enriched orange juice on postprandial metabolism and satiety in a healthy adult population. Methods: In this double-blind, randomised, placebo-controlled, crossover study 10 healthy subjects underwent two one-day trials in which they consumed an orange juice beverage containing 1.4 g/100 mL of citrus fibre (29.3% soluble and 41.9% insoluble) or a placebo (regular orange juice without added fibre). Postprandial glucose, insulin, gut hormones (GLP1, GIP and ghrelin…

Blood GlucoseDietary FiberMale0301 basic medicineTime Factorsgut hormonesmedicine.medical_treatmentsatietyAppetite0302 clinical medicineBlood serumGlucagon-Like Peptide 1media_commonCross-Over StudiesNutrition and DieteticsLeptinglycaemiaPostprandial PeriodGhrelinHealthy VolunteersFruit and Vegetable JuicesPostprandialFemaleCitrus sinensisAdultmedicine.medical_specialtyinsulinmedia_common.quotation_subjectBlood sugar030209 endocrinology & metabolismSatiationArticlecitrus fibreYoung Adult03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansOrange juice030109 nutrition & dieteticsbusiness.industryInsulinAppetiteCrossover studyEndocrinologyGlycemic Indexorange juicehealthy subjectsbusinessFood ScienceNutrients
researchProduct

Effects of dietary fiber intake on risk factors for cardiovascular disease in subjects at high risk

2009

Background: Epidemiological studies and feeding trials with supplements suggest that fibre intake is associated with a reduction in cardiovascular risk. However, the effects of changes in dietary fibre on risk factor levels have not been evaluated in free-living individuals. Thus, the effects of changes in dietary fibre intake on cardiovascular risk factors were assessed over 3 months in free-living high-risk subjects. Methods: 772 high-risk subjects (age 69±5 years) were assigned to a low-fat diet or two Mediterranean-style diets. All participants received behavioural and nutritional education, including recommendations for increasing the consumption of vegetables, fruits, and legumes. Cha…

Blood GlucoseMale030309 nutrition & dieteticsEpidemiologyBlood lipidsPhysiology030204 cardiovascular system & hematologyDiet Mediterraneanchemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinUNESCO::CIENCIAS MÉDICAS ::Salud públicaDiet Fat-Restricted2. Zero hunger0303 health sciencesEvidence-Based MedicineMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Cardiovascular diseaseDietary fiberHigh risk subjects3. Good healthC-Reactive ProteinCardiovascular diseasesCholesterolEstudi de casosCardiovascular DiseasesUNESCO::CIENCIAS MÉDICASCohortCytokinesFemalemedicine.medical_specialtyWaistDiet therapyC-reactive proteinARTHEROSCLEROSIS03 medical and health sciencesInternal medicinemedicineFibra alimentàriaHumans:CIENCIAS MÉDICAS ::Salud pública [UNESCO]Blood glucoseDietary fiber ; Risk factors ; Cardiovascular disease ; High risk subjectsRisk factorEpidemiologiaAgedNutritionCholesterolbusiness.industryMalalties cardiovascularsCholesterol HDLPublic Health Environmental and Occupational HealthCholesterol LDLAtherosclerosisBlood pressureEndocrinologychemistryRisk factorsCase studiessense organsbusinessEnergy Intake
researchProduct

Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized c…

2016

Background & aims: Inositols are thought to be mediators of the insulin signalling pathway. We assessed the effects of inositols on glycaemic control in fasting and postprandial states and evaluated lipoprotein profile and LDL particle size in healthy population. Methods: A 12-week double-blind clinical trial was performed with forty healthy subjects administered either an inositol-enriched beverage (IEB) -containing 2.23 g of inositols in 250 ml- or a sucrose-sweetened beverage (SB) twice a day. Anthropometric measurements, fasting glucose levels, insulin and HOMA-IR index, lipoprotein profile and postprandial glucose concentrations (measured using the continuous glucose monitoring system …

Blood GlucoseMaleApolipoprotein Bmedicine.medical_treatment030204 cardiovascular system & hematologyCritical Care and Intensive Care Medicinelaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawContinuous glucose monitoring systemHealthy subjects030212 general & internal medicineHypolipidemic AgentsNutrition and DieteticsbiologyArea under the curveFabaceaePostprandial PeriodPostprandialLDL particle sizeSeedsFemaleInositolsAdultmedicine.medical_specialtyCarob pod extractMonitoring AmbulatoryHyperlipidemias03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansHypoglycemic AgentsParticle SizePinitolPlant Extractsbusiness.industryPinitolInsulinMetabolismEndocrinologyLipoproteins IDLchemistrySpainFruitHyperglycemiaDietary Supplementsbiology.proteinInsulin ResistancebusinessInositolLipoproteinClinical Nutrition
researchProduct

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-…

2017

Background: \ud Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes.\ud \ud Methods: \ud In this randomised, double-blind, placebo-controlled trial, adults with prediabetes and a body-mass index of at least 30 kg/m2, or at least 27 kg/m2 with comorbidities, were randomised 2:1, using a telephone or web-based system, to once-daily subcutaneous liraglutide 3·0 mg or matched placebo, as an adjunct to a reduced-…

Blood GlucoseMaleEXENATIDEType 2 diabetes030204 cardiovascular system & hematologyBody Mass Indexlaw.inventionPlacebosImpaired glucose toleranceMELLITUS3.0 MG0302 clinical medicineRandomized controlled trialGlucagon-Like Peptide 1lawPREVENTION PROGRAM OUTCOMESPrediabetesPREVENTION PROGRAM OUTCOMES; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; CLINICAL-TRIAL; OBESE SUBJECTS; 3.0 MG; REGRESSION; EXENATIDE; MELLITUSSubcutaneousMedicine (all)General MedicineMiddle AgedAdult; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus Type 2; Double-Blind Method; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incretins; Injections Subcutaneous; Liraglutide; Male; Middle Aged; Obesity; Placebos; Prediabetic State; Risk Reduction Behavior; Treatment Outcome; Weight Loss3. Good healthTreatment OutcomeFemaleLIFE-STYLEType 2OBESE SUBJECTSmedicine.drugAdultmedicine.medical_specialtyInjections Subcutaneous030209 endocrinology & metabolismPlaceboIncretinsGlucagon-Like Peptide-1 ReceptorInjectionsCLINICAL-TRIALPrediabetic State03 medical and health sciencesIMPAIRED GLUCOSE-TOLERANCEDouble-Blind MethodDiabetes mellitusInternal medicineWeight LossREGRESSIONDiabetes MellitusmedicineHumansHypoglycemic AgentsObesityLiraglutidebusiness.industryBody WeightLiraglutidemedicine.diseaseClinical trialEndocrinologyDiabetes Mellitus Type 2Human medicinebusinessRisk Reduction Behavior[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe Lancet
researchProduct

Does ethanol intake interfere with the evaluation of glycated hemoglobins?

1989

Ethanol and/or its metabolites interfere with the chromatographic assay of glycated hemoglobins. Fasting plasma glucose, blood ethanol, HbA(1), HbA(1c), HbA(1a+b), MCV and GGT were determined in 22 control subjects; 22 alcoholics, 22 diabetic patients and 22 alcoholic diabetic patients. Fasting plasma glucose and all hemoglobin fractions were lower in alcoholic subjects and, except for HbA(1a+b), higher in diabetic patients and in alcoholic diabetic patients. HbA(1), and HbA(1c) correlated well with plasma glucose but not with blood ethanol, MCV and GGT. Glycated hemoglobin was not found to be a useful marker for alcohol abuse. With the chromatographic method we used, the evaluation of glyc…

Blood GlucoseMalemedicine.medical_specialtyAlcohol DrinkingEndocrinology Diabetes and MetabolismAlcohol abusechemistry.chemical_compoundEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineDiabetes MellitusHumansGlycated HemoglobinEthanolEthanolbusiness.industryGeneral MedicineFastingMiddle Agedmedicine.diseaseControl subjectsAlcoholismEndocrinologyDiabetes Mellitus Type 1chemistryDiabetes Mellitus Type 2Metabolic control analysisFemaleGlycated hemoglobinHemoglobinEthanol intakebusinessActa diabetologica latina
researchProduct